SCHEMBL5589189

SCHEMBL5589189

CCCc1cc(OC(=O)O)c(O)c(-c2ccccc2)c1CCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.38
PPARA Q07869 1/20 0.38
LTB4R Q15722 2/20 0.38
LTB4R2 Q9NPC1 2/20 0.38
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
NCEH1 Q6PIU2 1/20 0.37
CNR2 P34972 1/20 0.37
LDHA P00338 1/20 0.36
LDHB P07195 1/20 0.36
DPP4 P27487 1/20 0.36
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589810 0.94 CNR2 (0.40) PPARGPPARALTB4RLTB4R2NCEH1
SCHEMBL5588022 0.94 LTB4R (0.38) PPARGPPARALTB4RLTB4R2PDE4A
SCHEMBL5589825 0.90 CNR2 (0.41) PPARGPPARALTB4RLTB4R2NCEH1
SCHEMBL5586756 0.87 CNR2 (0.37) PPARGPPARALTB4RLTB4R2PDE4A
SCHEMBL5590131 0.86 CNR2 (0.40) PPARGPPARALTB4RLTB4R2PDE4A
SCHEMBL5587373 0.85 ESR1 (0.40) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL5589366 0.82 PRKCI (0.38) PDE4APDE4BPDE4CPDE4DNCEH1
SCHEMBL5589064 0.82 HMGCR (0.41) PPARGPPARALDHALDHBHMGCR
SCHEMBL5588866 0.80 KDM4E (0.38) PPARGPPARAPDE4APDE4BPDE4C
SCHEMBL5588532 0.80 CNR2 (0.41) PPARGPPARACNR2ALDH1A1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 PPARG 3592/4885PPARA 2921/4885LTB4R 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.